Suchergebnisse - "Alshammari, Thamir M"

PubPharm (6)

1

Association between proton pump inhibitors and rhabdomyolysis risk : a post-marketing surveillance using FDA adverse event reporting system (FAERS) database

enthalten in: Therapeutic advances in drug safety | 2023

von Altebainawi, A. | Alfaraj, L. | Alharbi, A. | +2

2

Impact of risk communication on patient's safety during the pandemic

enthalten in: Therapeutic advances in drug safety | 2023

von Zuluaga-Arias, H. | Alkhakany, M. | Younus, M. | +5

3

Direct healthcare professional communications : A quantitative assessment study

enthalten in: Pharmacology research & perspectives | 2021

von Alsaleh, H. | Alshammari, T.

4

National pharmacovigilance programs in Arab countries : A quantitative assessment study

enthalten in: Pharmacoepidemiology and drug safety | 2020

von Alshammari, T. | Alenzi, K. | Ata, S.

5

Factors that facilitate reporting of adverse drug reactions by pharmacists in Saudi Arabia

enthalten in: Expert opinion on drug safety | 2019

von Aldryhim, A. | Alomair, A. | Alqhtani, M. | +9

6

Factors that facilitate reporting of adverse drug reactions by pharmacists in Saudi Arabia

enthalten in: Expert opinion on drug safety | 2019

von Aldryhim, A. | Alomair, A. | Alqhtani, M. | +9

1
[1]